Russia says search for a coronavirus treatment should not be a medical ‘arms race’


14 May 2020 - Russia’s sovereign wealth fund has been funding Russian development and production of the drug favipiravir, an anti-influenza drug first developed in Japan under the name Avigan.

Russia has said an antiviral drug it’s funding has shown promising results in early clinical trials and has called for a global, collaborative approach to finding an effective treatment for the coronavirus.

The fund has provided $2 million in funding for the project.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder